BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Middleton K, Jones J, Lwin Z, Coward JI. Interleukin-6: an angiogenic target in solid tumours. Crit Rev Oncol Hematol. 2014;89:129-139. [PMID: 24029605 DOI: 10.1016/j.critrevonc.2013.08.004] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 9.4] [Reference Citation Analysis]
Number Citing Articles
1 Ai H, Zhou Z, Sun L, Yang M, Li W, Yu C, Song Z, Huang Y, Wu Y, Liu L, Yang X, Zhao Y, Bao Y, Li Y. 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol negatively regulates activation of STAT3 and ERK pathways and exhibits anti-cancer effects in HepG2 cells. Apoptosis 2017;22:1404-18. [DOI: 10.1007/s10495-017-1416-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
2 Kiartivich S, Wei Y, Liu J, Soiampornkul R, Li M, Zhang H, Dong J. Regulation of cytotoxicity and apoptosis-associated pathways contributes to the enhancement of efficacy of cisplatin by baicalein adjuvant in human A549 lung cancer cells. Oncol Lett 2017;13:2799-804. [PMID: 28454469 DOI: 10.3892/ol.2017.5746] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
3 Ota Y, Takahari D, Suzuki T, Osumi H, Nakayama I, Oki A, Wakatsuki T, Ichimura T, Ogura M, Shinozaki E, Suenaga M, Chin K, Yamaguchi K. Changes in the neutrophil-to-lymphocyte ratio during nivolumab monotherapy are associated with gastric cancer survival. Cancer Chemother Pharmacol 2020;85:265-72. [PMID: 31907646 DOI: 10.1007/s00280-019-04023-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
4 Tsoli M, Swarbrick MM, Robertson GR. Lipolytic and thermogenic depletion of adipose tissue in cancer cachexia. Semin Cell Dev Biol 2016;54:68-81. [PMID: 26529279 DOI: 10.1016/j.semcdb.2015.10.039] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
5 Hiramoto K, Yamate Y, Sugiyama D, Matsuda K, Iizuka Y, Yamaguchi T. Tranexamic Acid Ameliorates Nonmelanoma Skin Cancer Induced by Long‐term Ultraviolet A Irradiation. Photochem Photobiol 2018;95:612-7. [DOI: 10.1111/php.13025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Dominiak A, Chełstowska B, Olejarz W, Nowicka G. Communication in the Cancer Microenvironment as a Target for Therapeutic Interventions. Cancers (Basel) 2020;12:E1232. [PMID: 32422889 DOI: 10.3390/cancers12051232] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
7 Mathonnet M, Perraud A, Christou N, Akil H, Melin C, Battu S, Jauberteau MO, Denizot Y. Hallmarks in colorectal cancer: Angiogenesis and cancer stem-like cells. World J Gastroenterol 2014; 20(15): 4189-4196 [PMID: 24764657 DOI: 10.3748/wjg.v20.i15.4189] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 54] [Article Influence: 7.5] [Reference Citation Analysis]
8 Ji L, Jiang F, Cui X, Qin C. Talin1 knockdown prohibits the proliferation and migration of colorectal cancer cells via the EMT signaling pathway. Oncol Lett 2019;18:5408-16. [PMID: 31612049 DOI: 10.3892/ol.2019.10902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
9 Peleli M, Moustakas A, Papapetropoulos A. Endothelial-Tumor Cell Interaction in Brain and CNS Malignancies. Int J Mol Sci 2020;21:E7371. [PMID: 33036204 DOI: 10.3390/ijms21197371] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Fu Q, Liu P, Sun X, Huang S, Han F, Zhang L, Xu Y, Liu T. Ribonucleic acid interference knockdown of IL-6 enhances the efficacy of cisplatin in laryngeal cancer stem cells by down-regulating the IL-6/STAT3/HIF1 pathway. Cancer Cell Int 2017;17:79. [PMID: 28878571 DOI: 10.1186/s12935-017-0448-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
11 Pu CM, Liu CW, Liang CJ, Yen YH, Chen SH, Jiang-Shieh YF, Chien CL, Chen YC, Chen YL. Adipose-Derived Stem Cells Protect Skin Flaps against Ischemia/Reperfusion Injury via IL-6 Expression. J Invest Dermatol 2017;137:1353-62. [PMID: 28163069 DOI: 10.1016/j.jid.2016.12.030] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 11.6] [Reference Citation Analysis]
12 Mondal A, Smith C, DuHadaway JB, Sutanto-Ward E, Prendergast GC, Bravo-Nuevo A, Muller AJ. IDO1 is an Integral Mediator of Inflammatory Neovascularization. EBioMedicine 2016;14:74-82. [PMID: 27889479 DOI: 10.1016/j.ebiom.2016.11.013] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 6.7] [Reference Citation Analysis]
13 Sisler JD, Pirela SV, Friend S, Farcas M, Schwegler-Berry D, Shvedova A, Castranova V, Demokritou P, Qian Y. Small airway epithelial cells exposure to printer-emitted engineered nanoparticles induces cellular effects on human microvascular endothelial cells in an alveolar-capillary co-culture model. Nanotoxicology 2015;9:769-79. [PMID: 25387250 DOI: 10.3109/17435390.2014.976603] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
14 Kumar G, Goldberg SN, Gourevitch S, Levchenko T, Torchilin V, Galun E, Ahmed M. Targeting STAT3 to Suppress Systemic Pro-Oncogenic Effects from Hepatic Radiofrequency Ablation. Radiology 2018;286:524-36. [PMID: 28880787 DOI: 10.1148/radiol.2017162943] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
15 Hytti M, Tokarz P, Määttä E, Piippo N, Korhonen E, Suuronen T, Honkakoski P, Kaarniranta K, Lahtela-Kakkonen M, Kauppinen A. Inhibition of BET bromodomains alleviates inflammation in human RPE cells. Biochem Pharmacol 2016;110-111:71-9. [PMID: 27106081 DOI: 10.1016/j.bcp.2016.04.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
16 Drerup JM, Liu Y, Padron AS, Murthy K, Hurez V, Zhang B, Curiel TJ. Immunotherapy for ovarian cancer. Curr Treat Options Oncol 2015;16:317. [PMID: 25648541 DOI: 10.1007/s11864-014-0317-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
17 Lynch AM, Berning AA, Thevarajah TS, Wagner BD, Post MD, McCourt EA, Cathcart JN, Hodges JK, Mandava N, Gibbs RS, Palestine AG. The role of the maternal and fetal inflammatory response in retinopathy of prematurity. Am J Reprod Immunol 2018;80:e12986. [PMID: 29797537 DOI: 10.1111/aji.12986] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
18 Yang J, Wang J, Luo J. Decreased IL-6 induces sensitivity of hepatocellular carcinoma cells to sorafenib. Pathology - Research and Practice 2019;215:152565. [DOI: 10.1016/j.prp.2019.152565] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
19 Magrini E, Villa A, Angiolini F, Doni A, Mazzarol G, Rudini N, Maddaluno L, Komuta M, Topal B, Prenen H, Schachner M, Confalonieri S, Dejana E, Bianchi F, Mazzone M, Cavallaro U. Endothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalization. J Clin Invest 2014;124:4335-50. [PMID: 25157817 DOI: 10.1172/JCI70683] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
20 Brábek J, Jakubek M, Vellieux F, Novotný J, Kolář M, Lacina L, Szabo P, Strnadová K, Rösel D, Dvořánková B, Smetana K Jr. Interleukin-6: Molecule in the Intersection of Cancer, Ageing and COVID-19. Int J Mol Sci 2020;21:E7937. [PMID: 33114676 DOI: 10.3390/ijms21217937] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
21 Markezana A, Goldberg SN, Kumar G, Zorde-Khvalevsky E, Gourevtich S, Rozenblum N, Galun E, Ahmed M. Incomplete thermal ablation of tumors promotes increased tumorigenesis. Int J Hyperthermia 2021;38:263-72. [PMID: 33612046 DOI: 10.1080/02656736.2021.1887942] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Zhang Z, Zhang F, Lu Y, Zheng S. Update on implications and mechanisms of angiogenesis in liver fibrosis. Hepatol Res 2015;45:162-78. [PMID: 25196587 DOI: 10.1111/hepr.12415] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
23 Yuzhalin AE, Kutikhin AG. IL-6 Family and Cancer. Interleukins in Cancer Biology. Elsevier; 2015. pp. 117-46. [DOI: 10.1016/b978-0-12-801121-8.00005-1] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
24 Jóźwiak M, Struga M, Roszkowski P, Filipek A, Nowicka G, Olejarz W. Anticancer effects of alloxanthoxyletin and fatty acids esters - In vitro study on cancer HTB-140 and A549 cells. Biomed Pharmacother 2019;110:618-30. [PMID: 30544062 DOI: 10.1016/j.biopha.2018.12.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
25 Kuroyanagi G, Adapala NS, Yamaguchi R, Kamiya N, Deng Z, Aruwajoye O, Kutschke M, Chen E, Jo C, Ren Y, Kim HK. Interleukin-6 deletion stimulates revascularization and new bone formation following ischemic osteonecrosis in a murine model. Bone 2018;116:221-31. [DOI: 10.1016/j.bone.2018.08.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
26 Xiu L, Yang Z, Zhao Y, Liu X, Jiao J, Ye M, Sun D, Wei P. High-fat diets promote colon orthotopic transplantation tumor metastasis in BALB/c mice. Oncol Lett 2019;17:1914-20. [PMID: 30675255 DOI: 10.3892/ol.2018.9742] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Ma X, Ning S. Cyanidin-3-glucoside attenuates the angiogenesis of breast cancer via inhibiting STAT3/VEGF pathway. Phytother Res 2019;33:81-9. [PMID: 30251280 DOI: 10.1002/ptr.6201] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
28 Seki T, Yanaihara N, Shapiro JS, Saito M, Tabata J, Yokomizo R, Noguchi D, Kuroda T, Kawabata A, Suzuki J, Takahashi K, Matsuzawa H, Miyake M, Takenaka M, Iida Y, Yanagida S, Okamoto A. Interleukin-6 as an enhancer of anti-angiogenic therapy for ovarian clear cell carcinoma. Sci Rep 2021;11:7689. [PMID: 33833265 DOI: 10.1038/s41598-021-86913-9] [Reference Citation Analysis]
29 Pilskog M, Beisland C, Akslen LA, Bostad L, Haug Å, Heinrich D, Hjelle KM, Straume O. Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. BMC Urol 2017;17:74. [PMID: 28859644 DOI: 10.1186/s12894-017-0267-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
30 Taniguchi K, Karin M. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Seminars in Immunology. 2014;26:54-74. [PMID: 24552665 DOI: 10.1016/j.smim.2014.01.001] [Cited by in Crossref: 319] [Cited by in F6Publishing: 319] [Article Influence: 39.9] [Reference Citation Analysis]
31 Tong Q, Wang XL, Li SB, Yang GL, Jin S, Gao ZY, Liu XB. Combined detection of IL-6 and IL-8 is beneficial to the diagnosis of early stage esophageal squamous cell cancer: a preliminary study based on the screening of serum markers using protein chips. Onco Targets Ther. 2018;11:5777-5787. [PMID: 30254470 DOI: 10.2147/ott.s171242] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
32 Miyatani K, Saito H, Kono Y, Murakami Y, Kuroda H, Matsunaga T, Fukumoto Y, Osaki T, Ashida K, Fujiwara Y. Combined analysis of the pre- and postoperative neutrophil–lymphocyte ratio predicts the outcomes of patients with gastric cancer. Surg Today 2018;48:300-7. [DOI: 10.1007/s00595-017-1587-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
33 Simpson A, Caballero O. Monoclonal antibodies for the therapy of cancer. BMC Proc 2014;8. [DOI: 10.1186/1753-6561-8-s4-o6] [Cited by in Crossref: 9] [Article Influence: 1.1] [Reference Citation Analysis]
34 Zhang C, Ma K, Li WY. IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway. J Cancer 2019;10:6511-25. [PMID: 31777581 DOI: 10.7150/jca.29931] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
35 Ock CY, Nam AR, Lee J, Bang JH, Lee KH, Han SW, Kim TY, Im SA, Kim TY, Bang YJ, Oh DY. Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer. Gastric Cancer. 2017;20:254-262. [PMID: 27147244 DOI: 10.1007/s10120-016-0613-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
36 He L, Wei J, Liu D, Zhao W, Chen Y. Atg7 Silencing Inhibits Laminin‐5 Expression to Suppress Tube Formation by Brain Endothelial Cells. Anat Rec 2019;302:2255-60. [DOI: 10.1002/ar.24223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Gyamfi J, Eom M, Koo JS, Choi J. Multifaceted Roles of Interleukin-6 in Adipocyte-Breast Cancer Cell Interaction. Transl Oncol 2018;11:275-85. [PMID: 29413760 DOI: 10.1016/j.tranon.2017.12.009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 9.3] [Reference Citation Analysis]
38 Velikova TV, Miteva L, Stanilov N, Spassova Z, Stanilova SA. Interleukin-6 compared to the other Th17/Treg related cytokines in inflammatory bowel disease and colorectal cancer. World J Gastroenterol 2020; 26(16): 1912-1925 [PMID: 32390702 DOI: 10.3748/wjg.v26.i16.1912] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
39 Abdul Rahim SN, Ho GY, Coward JI. The role of interleukin-6 in malignant mesothelioma. Transl Lung Cancer Res 2015;4:55-66. [PMID: 25806346 DOI: 10.3978/j.issn.2218-6751.2014.07.01] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
40 Matsusaka S, Hanna DL, Cao S, Zhang W, Yang D, Ning Y, Sunakawa Y, Okazaki S, Berger MD, Miyamato Y, Parekh A, Stintzing S, Loupakis F, Lenz HJ. Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy. Clin Cancer Res 2016;22:3218-26. [PMID: 26839145 DOI: 10.1158/1078-0432.CCR-15-2422] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
41 Salvati L, Occhipinti M, Gori L, Ciani L, Mazzoni A, Maggi L, Capone M, Parronchi P, Liotta F, Miele V, Annunziato F, Lavorini F, Cosmi L. Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab. Immunol Lett 2020;228:122-8. [PMID: 33161002 DOI: 10.1016/j.imlet.2020.10.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
42 Casanova Barea J, De la Gala F, Piñeiro P, Reyes A, Simón C, Rancan L, Vara E, Paredes S, Bellón JM, Garutti Martinez I. Influence of postoperative complications on long-term outcome after oncologic lung resection surgery. Substudy of a randomized control trial. J Clin Monit Comput 2021;35:1183-92. [PMID: 32797324 DOI: 10.1007/s10877-020-00580-1] [Reference Citation Analysis]
43 Farolfi A, Petrone M, Scarpi E, Gallà V, Greco F, Casanova C, Longo L, Cormio G, Orditura M, Bologna A, Zavallone L, Ventriglia J, Franzese E, Loizzi V, Giardina D, Pigozzi E, Cioffi R, Pignata S, Giorda G, De Giorgi U. Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24). Target Oncol 2018;13:469-79. [PMID: 29948780 DOI: 10.1007/s11523-018-0574-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
44 Pilskog M, Nilsen GH, Beisland C, Straume O. Elevated plasma interleukin 6 predicts poor response in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. Cancer Treat Res Commun 2019;19:100127. [PMID: 30913495 DOI: 10.1016/j.ctarc.2019.100127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
45 Heiss RU, Fahlbusch FB, Jacobi J, Daniel C, Ekici AB, Cordasic N, Amann K, Hartner A, Hilgers KF. Blunted transcriptional response to skeletal muscle ischemia in rats with chronic kidney disease: potential role for impaired ischemia-induced angiogenesis. Physiol Genomics 2017;49:230-7. [PMID: 28213570 DOI: 10.1152/physiolgenomics.00124.2016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
46 Shi M, Xia L, Chen Z, Lv F, Zhu H, Wei F, Han S, Chang J, Xiao Y, Wu C. Europium-doped mesoporous silica nanosphere as an immune-modulating osteogenesis/angiogenesis agent. Biomaterials 2017;144:176-87. [DOI: 10.1016/j.biomaterials.2017.08.027] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 13.6] [Reference Citation Analysis]
47 Hutton DA, Clayton ZS. Physical activity-related suppression of cancer growth: is a transient increase in cytokine production required for tumour angiogenesis? J Physiol 2019;597:4137-8. [PMID: 31298739 DOI: 10.1113/JP278347] [Reference Citation Analysis]
48 Sarkar C, Goswami S, Basu S, Chakroborty D. Angiogenesis Inhibition in Prostate Cancer: An Update. Cancers (Basel) 2020;12:E2382. [PMID: 32842503 DOI: 10.3390/cancers12092382] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
49 Lin Y, He Z, Ye J, Liu Z, She X, Gao X, Liang R. Progress in Understanding the IL-6/STAT3 Pathway in Colorectal Cancer. Onco Targets Ther 2020;13:13023-32. [PMID: 33376351 DOI: 10.2147/OTT.S278013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
50 Ribot J, Caliaperoumal G, Paquet J, Boisson-Vidal C, Petite H, Anagnostou F. Type 2 diabetes alters mesenchymal stem cell secretome composition and angiogenic properties. J Cell Mol Med 2017;21:349-63. [PMID: 27641937 DOI: 10.1111/jcmm.12969] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
51 Catar R, Witowski J, Zhu N, Lücht C, Derrac Soria A, Uceda Fernandez J, Chen L, Jones SA, Fielding CA, Rudolf A, Topley N, Dragun D, Jörres A. IL-6 Trans-Signaling Links Inflammation with Angiogenesis in the Peritoneal Membrane. J Am Soc Nephrol 2017;28:1188-99. [PMID: 27837150 DOI: 10.1681/ASN.2015101169] [Cited by in Crossref: 37] [Cited by in F6Publishing: 18] [Article Influence: 6.2] [Reference Citation Analysis]
52 Shimizu S, Saito H, Kono Y, Murakami Y, Shishido Y, Miyatani K, Matsunaga T, Fukumoto Y, Fujiwara Y. The prognostic significance of the comprehensive complication index in patients with gastric cancer. Surg Today 2019;49:913-20. [PMID: 31147763 DOI: 10.1007/s00595-019-01828-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
53 Schmohl KA, Nelson PJ, Spitzweg C. Tetrac as an anti-angiogenic agent in cancer. Endocr Relat Cancer 2019;26:R287-304. [PMID: 31063970 DOI: 10.1530/ERC-19-0058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
54 Lee EJ, Lee SJ, Kim JH, Kim KJ, Yang SH, Jeong KY, Seong J. Radiation Inhibits Interleukin-12 Production via Inhibition of C-Rel through the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Signaling Pathway in Dendritic Cells. PLoS One 2016;11:e0146463. [PMID: 26745884 DOI: 10.1371/journal.pone.0146463] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
55 Liang S, Chen Z, Jiang G, Zhou Y, Liu Q, Su Q, Wei W, Du J, Wang H. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals. Cancer Lett 2017;386:12-23. [PMID: 27836733 DOI: 10.1016/j.canlet.2016.11.003] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 9.2] [Reference Citation Analysis]
56 Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014;2014:149185. [PMID: 24901008 DOI: 10.1155/2014/149185] [Cited by in Crossref: 715] [Cited by in F6Publishing: 748] [Article Influence: 89.4] [Reference Citation Analysis]
57 Wang X, Gao Y, Zhang X, Wang X, Wang B, Meng X, Yoshikai Y, Wang Y, Sun X. CD30L/CD30 signaling regulates the formation of the tumor immune microenvironment and inhibits intestinal tumor development of colitis-associated colon cancer in mice. Int Immunopharmacol 2020;84:106531. [PMID: 32353687 DOI: 10.1016/j.intimp.2020.106531] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
58 Zadeh JK, Ruemmler R, Hartmann EK, Ziebart A, Ludwig M, Patzak A, Xia N, Li H, Pfeiffer N, Gericke A. Responses of retinal arterioles and ciliary arteries in pigs with acute respiratory distress syndrome (ARDS). Experimental Eye Research 2019;184:152-61. [DOI: 10.1016/j.exer.2019.04.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
59 Hara M, Nagasaki T, Shiga K, Takahashi H, Takeyama H. High serum levels of interleukin-6 in patients with advanced or metastatic colorectal cancer: the effect on the outcome and the response to chemotherapy plus bevacizumab. Surg Today 2017;47:483-9. [PMID: 27549777 DOI: 10.1007/s00595-016-1404-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
60 Liu C, Zhao Q, Yu X. Bone Marrow Adipocytes, Adipocytokines, and Breast Cancer Cells: Novel Implications in Bone Metastasis of Breast Cancer. Front Oncol 2020;10:561595. [PMID: 33123472 DOI: 10.3389/fonc.2020.561595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Wang Z, Wu P, Wu D, Zhang Z, Hu G, Zhao S, Lai Y, Huang J. Prognostic and clinicopathological significance of serum interleukin-6 expression in colorectal cancer: a systematic review and meta-analysis. Onco Targets Ther 2015;8:3793-801. [PMID: 26719707 DOI: 10.2147/OTT.S93297] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
62 Ribatti D. Interleukins as modulators of angiogenesis and anti-angiogenesis in tumors. Cytokine 2019;118:3-7. [DOI: 10.1016/j.cyto.2018.10.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
63 Han J, Xi Q, Meng Q, Liu J, Zhang Y, Han Y, Zhuang Q, Jiang Y, Ding Q, Wu G. Interleukin-6 promotes tumor progression in colitis-associated colorectal cancer through HIF-1α regulation. Oncol Lett 2016;12:4665-70. [PMID: 28105173 DOI: 10.3892/ol.2016.5227] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
64 Liu G, Zhang J, Frey L, Gang X, Wu K, Liu Q, Lilly M, Wu J. Prostate-specific IL-6 transgene autonomously induce prostate neoplasm through amplifying inflammation in the prostate and peri-prostatic adipose tissue. J Hematol Oncol 2017;10:14. [PMID: 28077171 DOI: 10.1186/s13045-016-0386-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
65 Wang Y, Li JX, Wang YQ, Miao ZH. Tanshinone I inhibits tumor angiogenesis by reducing Stat3 phosphorylation at Tyr705 and hypoxia-induced HIF-1α accumulation in both endothelial and tumor cells. Oncotarget 2015;6:16031-42. [PMID: 26202747 DOI: 10.18632/oncotarget.3648] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
66 Liu YC, Stone K, van Rhee F. Siltuximab for multicentric Castleman disease. Expert Rev Hematol 2014;7:545-57. [PMID: 25110138 DOI: 10.1586/17474086.2014.946402] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
67 Gu H, Huang T, Shen Y, Liu Y, Zhou F, Jin Y, Sattar H, Wei Y. Reactive Oxygen Species-Mediated Tumor Microenvironment Transformation: The Mechanism of Radioresistant Gastric Cancer. Oxid Med Cell Longev 2018;2018:5801209. [PMID: 29770167 DOI: 10.1155/2018/5801209] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
68 Zhuang SF, Liu DX, Wang HJ, Zhang SH, Wei JY, Fang WG, Zhang K, Cao L, Zhao WD, Chen YH. Atg7 Regulates Brain Angiogenesis via NF-κB-Dependent IL-6 Production. Int J Mol Sci 2017;18:E968. [PMID: 28467355 DOI: 10.3390/ijms18050968] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
69 Ni XF, Xie QQ, Zhao JM, Xu YJ, Ji M, Hu WW, Wu J, Wu CP. The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of YAP1. Aging (Albany NY) 2021;13:4357-69. [PMID: 33495421 DOI: 10.18632/aging.202397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Hatch AJ, Clarke JM, Nixon AB, Hurwitz HI. Identifying Blood-Based Protein Biomarkers for Antiangiogenic Agents in the Clinic: A Decade of Progress. The Cancer Journal 2015;21:322-6. [DOI: 10.1097/ppo.0000000000000129] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
71 Casey SC, Amedei A, Aquilano K, Azmi AS, Benencia F, Bhakta D, Bilsland AE, Boosani CS, Chen S, Ciriolo MR, Crawford S, Fujii H, Georgakilas AG, Guha G, Halicka D, Helferich WG, Heneberg P, Honoki K, Keith WN, Kerkar SP, Mohammed SI, Niccolai E, Nowsheen S, Vasantha Rupasinghe HP, Samadi A, Singh N, Talib WH, Venkateswaran V, Whelan RL, Yang X, Felsher DW. Cancer prevention and therapy through the modulation of the tumor microenvironment. Semin Cancer Biol. 2015;35 Suppl:S199-S223. [PMID: 25865775 DOI: 10.1016/j.semcancer.2015.02.007] [Cited by in Crossref: 149] [Cited by in F6Publishing: 144] [Article Influence: 21.3] [Reference Citation Analysis]
72 Liu S, Liu D, Zeng X, Wang J, Liu J, Cheng J, Lei K, Bai H, Ji N, Zhou M, Jiang L, Dan H, Li J, Chen Q. PA28γ acts as a dual regulator of IL-6 and CCL2 and contributes to tumor angiogenesis in oral squamous cell carcinoma. Cancer Lett 2018;428:192-200. [PMID: 29702196 DOI: 10.1016/j.canlet.2018.04.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
73 Pilskog M, Bostad L, Edelmann RJ, Akslen LA, Beisland C, Straume O. Tumour cell expression of interleukin 6 receptor α is associated with response rates in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. J Pathol Clin Res 2018;4:114-23. [PMID: 29665322 DOI: 10.1002/cjp2.96] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
74 Samuel PJ. Cytokine Analysis: A Fresh Perspective. J Interferon Cytokine Res 2020;40:511-4. [PMID: 33201764 DOI: 10.1089/jir.2020.0089] [Reference Citation Analysis]
75 Mochizuki D, Adams A, Warner KA, Zhang Z, Pearson AT, Misawa K, McLean SA, Wolf GT, Nör JE. Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma. Oncotarget 2015;6:22822-35. [PMID: 26287605 DOI: 10.18632/oncotarget.4477] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
76 Ma B, Dohle E, Li M, Kirkpatrick CJ. TLR4 stimulation by LPS enhances angiogenesis in a co-culture system consisting of primary human osteoblasts and outgrowth endothelial cells. J Tissue Eng Regen Med 2017;11:1779-91. [PMID: 26205614 DOI: 10.1002/term.2075] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
77 Zhang ZJ, Wang KP, Mo JG, Xiong L, Wen Y. Photodynamic therapy regulates fate of cancer stem cells through reactive oxygen species. World J Stem Cells 2020; 12(7): 562-584 [PMID: 32843914 DOI: 10.4252/wjsc.v12.i7.562] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
78 Lee Y, Kim SJ, Choo J, Heo G, Yoo JW, Jung Y, Rhee SH, Im E. miR-23a-3p is a Key Regulator of IL-17C-Induced Tumor Angiogenesis in Colorectal Cancer. Cells 2020;9:E1363. [PMID: 32492770 DOI: 10.3390/cells9061363] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
79 Davis PJ, Sudha T, Lin HY, Mousa SA. Thyroid Hormone, Hormone Analogs, and Angiogenesis. Compr Physiol 2015;6:353-62. [PMID: 26756636 DOI: 10.1002/cphy.c150011] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
80 Wierzbicki M, Sawosz E, Strojny B, Jaworski S, Grodzik M, Chwalibog A. NF-κB-related decrease of glioma angiogenic potential by graphite nanoparticles and graphene oxide nanoplatelets. Sci Rep 2018;8:14733. [PMID: 30283098 DOI: 10.1038/s41598-018-33179-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
81 Gyamfi J, Lee YH, Eom M, Choi J. Interleukin-6/STAT3 signalling regulates adipocyte induced epithelial-mesenchymal transition in breast cancer cells. Sci Rep 2018;8:8859. [PMID: 29891854 DOI: 10.1038/s41598-018-27184-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 12.0] [Reference Citation Analysis]
82 Ozsvar J, Mithieux SM, Wang R, Weiss AS. Elastin-based biomaterials and mesenchymal stem cells. Biomater Sci 2015;3:800-9. [PMID: 26146549 DOI: 10.1039/C5BM00038F] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]